ProQR Therapeutics N.V.
PRQR · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
de Boer Daniel Anton: Form 4
Insider disclosure · Filed · Report period 31 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- PRQR · N71542109 - Ordinary Shares, nominal value Euro 0.04 per share
Company details and SEC sources
CIK 0001612940 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PRQR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Zernikedreef 9, Leiden
- Incorporated in
- Netherlands
- Fiscal year end
- 31 December
- Former names on EDGAR
- ProQR Therapeutics B.V. (to 03 Oct 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields